Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host
a live webcast of its fiscal 2019 third-quarter conference call on
Wednesday, May 1, 2019, at 3:30 p.m. CT (4:30 p.m. ET). CSI management
will discuss results for its fiscal third quarter ended March 31, 2019,
and its financial outlook. The company will issue a post-market earnings
release prior to the call on May 1, 2019.
To access the live webcast, go to the events section of CSI’s investor
relations website, https://investors.csi360.com/events-and-presentations,
on the day of the conference, and click on the webcast link. A webcast
replay will be available beginning at 6:30 p.m. CT the same day.
To participate in the conference call, dial (833) 241-7255 and enter
5768999. Please dial in at least 10 minutes prior to the call.
About Cardiovascular Systems, Inc.
Systems, Inc., based in St. Paul, Minn., is a medical device company
focused on developing and commercializing innovative solutions for
treating vascular and coronary disease. The company’s OAS treat
calcified and fibrotic plaque in arterial vessels throughout the leg and
heart in a few minutes of treatment time, and address many of the
limitations associated with existing surgical, catheter and
pharmacological treatment alternatives. The U.S. FDA granted 510(k)
clearance for the use of the Diamondback Orbital Atherectomy System in
peripheral arteries in August 2007. In October 2013, the company
received FDA approval for the use of the Diamondback Orbital Atherectomy
System in coronary arteries. The Stealth 360® Peripheral
Orbital Atherectomy System (OAS) received CE Mark in October 2014. Over
400,000 of CSI’s devices have been sold to leading institutions